儿童心肌病:分类与诊断——美国心脏协会科学声明
该美国心脏协会科学声明聚焦儿童心肌病的病因与诊断,指出儿童心肌病发病率约1/10万,近40%有症状患儿在诊断后2年内死亡或接受心脏移植,且移植比例10年未降,心肌病仍是1岁以上儿童移植首要原因。声明强调多数病因未明确但遗传因素可能普遍存在,旨在推动早期诊断与改善预后。
要点
- 儿童心肌病发病率约1/10万,与部分儿童癌症相当。
- 近40%有症状患儿在诊断后2年内死亡或接受心脏移植。
- 心肌病是1岁以上儿童心脏移植的首要原因,移植比例10年未降。
核心结论
- 儿童心肌病预后差,近40%有症状患儿在诊断后2年内死亡或接受心脏移植。
- 心肌病是1岁以上儿童心脏移植的首要原因,且移植比例过去10年未下降。
- 尽管多数患儿病因未明确,但遗传因素可能普遍存在。
研究设计与样本
- 美国心脏协会组织心肌病领域专家制定的科学声明,聚焦儿童心肌病的病因与诊断分类。
主要发现
- 近40%的有症状心肌病患儿在诊断后2年内接受心脏移植或死亡。
- 接受心脏移植的儿童心肌病患者比例在过去10年未下降。
- 心肌病仍是1岁以上儿童心脏移植的首要原因。
- 美国国家心肺血液研究所资助的儿童心肌病注册研究显示,极少数患儿病因明确,但多数可能存在遗传病因。
临床怎么用
- 临床应关注儿童心肌病的早期识别与诊断分类,警惕遗传病因可能。
- 对症状性心肌病患儿需密切监测并评估心脏移植风险。
局限性
- 声明基于现有研究,儿童心肌病相关研究与科学会议远少于可比儿童癌症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In this scientific statement from the American Heart Association, experts in the field of cardiomyopathy (heart muscle disease) in children address 2 issues: the most current understanding of the causes of cardiomyopathy in children and the optimal approaches to diagnosis cardiomyopathy in children. Cardiomyopathies result in some of the worst pediatric cardiology outcomes; nearly 40% of children who present with symptomatic cardiomyopathy undergo a heart transplantation or die within the first 2 years after diagnosis. The percentage of children with cardiomyopathy who underwent a heart transplantation has not declined over the past 10 years, and cardiomyopathy remains the leading cause of transplantation for children >1 year of age. Studies from the National Heart, Lung, and Blood Institute-funded Pediatric Cardiomyopathy Registry have shown that causes are established in very few children with cardiomyopathy, yet genetic causes are likely to be present in most. The incidence of pediatric cardiomyopathy is ≈1 per 100 000 children. This is comparable to the incidence of such childhood cancers as lymphoma, Wilms tumor, and neuroblastoma. However, the published research and scientific conferences focused on pediatric cardiomyopathy are sparcer than for those cancers. The aim of the statement is to focus on the diagnosis and classification of cardiomyopathy. We anticipate that this report will help shape the future research priorities in this set of diseases to achieve earlier diagnosis, improved clinical outcomes, and better quality of life for these children and their families.
引用
- Lipshultz SE, Law YM, Asante-Korang A, et al. Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association. Circulation. 2019. PMID: 31132865. doi:10.1161/CIR.0000000000000682
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。